Table 2:
Overall% | P 1 | P2 | P 3 | P 4 | P 5 | P 6 | P 7 | P 8b | P 9 | P 10 | P 11 | P 12 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pregnancy and neonatal | |||||||||||||
| |||||||||||||
Complications during pregnancy | 40 | Yes (polyhydramnios) | Yes (bleeding) | No | Yes (gestational diabetes) | Yes (gestational diabetes, bleeding) | No | No | No | NA | No | No | NA |
Gestational age (wks) | 39 | 37 | 40 | 37 | 40 | 39 | 40 | 35 | NA | 39 | 39 | NA | |
Birthweight, kg (z-score)a | 4.1 (+1.4) | 3.1 (−0.3) | 3.7 (+1.0) | 2.6 (−1.5) | 3.3 (−0.1) | 3.5 (+0.6) | 3.7 (+0.7) | 2.3 (−0.5) | NA | 2.8 (−1.2) | 4.2 (+1.6) | NA | |
Neonatal complications | 90 | Yes (hypotonia, feeding difficulty, lethargy) | Yes (hypotonia, hyperbilirubinemia) | Yes (hypoglycemia) | Yes (temperature regulation, hyperbilirubinemia) | Yes (feeding difficulty, irritability, respiratory distress, hyperbilirubinemia) | Yes (meconium) | Yes (hypotonia) | Yes (feeding difficulty, respiratory distress, hyperbilirubinemia) | NA | No | Yes (poor suck, feeding difficulty, irritability) | NA |
| |||||||||||||
Neurodevelopmental and psychiatric | |||||||||||||
| |||||||||||||
Autism spectrum disorder | 50 | Yes | Yes | No | Yes | Yes | No | No | No | NA | No | Yes | NA |
Intellectual disability/developmental delay | 100 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NA | Yes | Yes | NA |
Language delay or impairment | 60 | Yes | No | No | No | No | Yes | Yes | Yes | NA | Yes | Yes | NA |
History of seizures | 25 | Yes | No | No | Yes | Yes | No | No | No | No | No | No | No |
Current diagnosis of epilepsy | 17 | Yes | No | No | No | Yes | No | No | No | No | No | No | No |
Macrocephaly | 10 | No | No | No | No | No | No | No | No | NA | No | Yes | NA |
Microcephaly | 30 | Yes | No | No | No | Yes | No | No | Yes | NA | No | No | NA |
Cerebral palsy | 30 | No | Yes | Yes | No | Yes | No | No | No | NA | No | No | NA |
Hypotonia | 90 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NA | Yes | No | NA |
Movement disorder | 40 | Yes | Yes | No | No | Yes | Yes | No | No | NA | No | No | NA |
ADHD | 10 | Yes | No | No | No | No | No | No | No | NA | No | No | NA |
Anxiety | 10 | No | No | No | No | No | No | No | Yes | NA | No | No | NA |
| |||||||||||||
Systemic | |||||||||||||
| |||||||||||||
Vision | |||||||||||||
| |||||||||||||
Hyperopia | 40 | Yes | No | Yes | No | Yes | No | No | No | NA | Yes | No | NA |
Myopia | 10 | No | No | No | No | No | No | No | No | NA | Yes | No | NA |
Strabismus | 50 | No | Yes | Yes | No | Yes | No | Yes | Yes | NA | No | No | NA |
Astigmatism | 10 | No | No | No | No | Yes | No | No | No | NA | No | No | NA |
Respiratory: asthma | 20 | Yes | No | No | Yes | No | No | No | No | NA | No | No | NA |
Gastrointestinal | |||||||||||||
Reflux | 50 | No | Yes | Yes | No | Yes | No | Yes | No | NA | Yes | No | NA |
Constipation | 30 | No | Yes | No | No | No | No | No | No | NA | Yes | Yes | NA |
Failure to thrive | 20 | Yes | No | No | No | Yes | No | No | No | NA | No | No | NA |
Genitourinary: vesicoureteral reflux | 10 | No | No | Yes | No | No | No | No | No | NA | No | No | NA |
Musculoskeletal: hip dysplasia | 10 | No | Yes | No | No | No | No | No | No | NA | No | No | NA |
Dermatological: eczema | 20 | No | No | No | Yes | Yes | No | No | No | NA | No | No | NA |
Immunodeficiency | 11 | No | Yes | No | No | No | No | No | No | NA | NA | No | NA |
For birthweight, z-scores were calculated using the World Health Organization infant weight for age charts for infants born at 37 weeks’ gestation and older.18
For Participant 8, the z-score was calculated using the Fenton 2013 growth chart for preterm infants.19 NA, data not available; ADHD, attention-deficit/hyperactivity disorder.